Chromosomal Microarray With Clinical Diagnostic Utility in Children With Developmental Delay or Intellectual Disability

BACKGROUND: Chromosomal microarray (CMA) testing is a first-tier test for patients with developmental delay, autism, or congenital anomalies. It increases diagnostic yield for patients with developmental delay or intellectual disability. In some countries, including Korea, CMA testing is not yet imp...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jin Sook, Hwang, Hee, Kim, Soo Yeon, Kim, Ki Joong, Choi, Jin Sun, Woo, Mi Jung, Choi, Young Min, Jun, Jong Kwan, Lim, Byung Chan, Chae, Jong-Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society for Laboratory Medicine 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973923/
https://www.ncbi.nlm.nih.gov/pubmed/29797819
http://dx.doi.org/10.3343/alm.2018.38.5.473

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973923/
https://www.ncbi.nlm.nih.gov/pubmed/29797819
http://dx.doi.org/10.3343/alm.2018.38.5.473

Ejemplares similares